PRIME-LA

A Dual Master's And Medical Degree Program

PRIME-LA Focuses on the Development of Community-Minded Leaders in Healthcare

View student projects

The PRIME-LA Program at the David Geffen School of Medicine at UCLA prepares and enables students to address real problems in real community situations.

See degree options

A focus on leadership and advocacy, with a long-term goal to develop leaders in medicine addressing policy, care, and research in healthcare for California communities.

Program FAQ

For general questions on the program, timelines, eligibility, application types, and what to expect on interview notification take a look at our FAQs page.

Support Our Future Physician Leaders

Donate

Headlines

View All News Articles

Fred Ramsdell, PhD

UCLA alumnus Fred Ramsdell wins 2025 Nobel Prize in physiology or medicine

UCLA alumnus Fred Ramsdell wins 2025 Nobel Prize in physiology or medicine

October 06, 2025

2 min read

Read the full article

Award winners pose for photo At the IEEE-EMBS International Conference on Body Sensor Networks

UCLA CASIT Researchers Shine at Prestigious International Conferences

CASIT researchers were recognized for their outstanding contributions at two major international conferences.

November 06, 2025

1 min read

DGSOM medical student Jose Segura-Bermudez posing with friends and family

The Aspiring Surgeon Taking a Stand for Latino Communities

UCLA medical student Jose Segura-Bermudez is becoming a doctor who provides compassionate, culturally competent care to Latino patients.

September 05, 2025

3 min read

Individuals on mats completing yoga poses

How physical activity may fight Parkinson’s disease symptoms

A UCLA study finds that physical activity may fight Parkinson’s disease symptoms

September 03, 2025

3 min read

Magnified view of a kidney cancer metastasis nodule (green) within mouse lung tissue (light purple).

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

An off-the-shelf immunotherapy for metastatic kidney cancer uses specially engineered immune cells to attack cancer tumors.

August 29, 2025

3 min read

UCLA PRIME-LA Stories

Discover more about student life